Related Experiment Video
Updated: Sep 5, 2025
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
DNA damage and metabolic mechanisms of cancer drug resistance
1The Ken & Ruth Davee Department of Neurology, Lou and Jean Malnati Brain Tumor Institute at Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, and Simpson Querry Institute for Epigenetics, Northwestern University, Feinberg School of Medicine, 303 E Superior St, Chicago, IL 60611, USA.
Abstract:
Cancer drug resistance is one of the main barriers to overcome to ensure durable treatment responses. While many pivotal advances have been made in first combination therapies, then targeted therapies, and now broadening out to immunomodulatory drugs or metabolic targeting compounds, drug resistance is still ultimately universally fatal. In this brief review, we will discuss different strategies that have been used to fight drug resistance from synthetic lethality to tumor microenvironment modulation, focusing on the DNA damage response and tumor metabolism both within tumor cells and their surrounding microenvironment. In this way, with a better understanding of both targetable mutations in combination with the metabolism, smarter drugs may be designed to combat cancer drug resistance.
Insights
Cancer drug resistance remains a major challenge, but new strategies like synthetic lethality and tumor microenvironment modulation offer hope. Understanding DNA damage response and tumor metabolism can lead to smarter cancer drug design.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Cancer drug resistance is a significant barrier to achieving durable treatment responses.
- Despite advances in combination, targeted, and immunomodulatory therapies, drug resistance remains a critical challenge.
- Understanding resistance mechanisms is crucial for developing effective cancer treatments.
Purpose of the Study:
- To review strategies for combating cancer drug resistance.
- To focus on synthetic lethality and tumor microenvironment modulation.
- To highlight the importance of DNA damage response and tumor metabolism in overcoming resistance.
Main Methods:
- Review of existing literature on cancer drug resistance strategies.
- Focus on synthetic lethality approaches.
- Analysis of tumor microenvironment modulation techniques.
- Examination of DNA damage response pathways.
- Investigation of tumor metabolism in cancer cells and the microenvironment.
Main Results:
- Various strategies exist to combat cancer drug resistance, including synthetic lethality and targeting the tumor microenvironment.
- Both DNA damage response and tumor metabolism are critical areas for intervention.
- Understanding the interplay between mutations and metabolism is key.
Conclusions:
- Developing smarter drugs requires a comprehensive understanding of targetable mutations and tumor metabolism.
- Modulating the tumor microenvironment and exploiting synthetic lethality are promising avenues.
- Further research into DNA damage response and metabolism can improve cancer treatment outcomes.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
02:25Overview of DNA Repair
Chemically...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
02:37DNA Damage can Stall the Cell Cycle
02:37DNA Damage Can Stall the Cell Cycle